Sensex 29182.95 -498.82 -1.68%
Nifty 8808.9 -143.45 -1.6%
India Infoline News Service | Mumbai January 28, 2015 11:28 IST
Biocon owns a promising portfolio but given the higher risks in biosimilars compared to small molecules and lack of near term triggers has led to stock derating over the past several months.
capital market | Mumbai January 28, 2015 10:22 IST
Biocon rose 0.58% to Rs 410.50 at 10:35 IST on BSE after Minister of State Dr. Jitendra Singh yesterday, 27 January 2015, said the government is keen to promote all kinds of upward activities in the biotech sector.
capital market | Mumbai January 23, 2015 10:46 IST
Sales rise 8.55% to Rs 761.09 crore
capital market | Mumbai January 23, 2015 10:37 IST
Sales rise 0.89% to Rs 507.94 crore
India Infoline News Service | Mumbai January 23, 2015 09:57 IST
The stock has hit a high of Rs. 422 and a low of Rs.411.
capital market | Mumbai January 23, 2015 09:56 IST
Biocon lost 3.26% to Rs 412.25 at 09:49 IST on BSE after the company's consolidated net profit fell 13.39% to Rs 90.93 crore on 8.25% rise in total income to Rs 778.99 crore in Q3 December 2014 over Q3 December 2013.
capital market | Mumbai January 23, 2015 09:14 IST
At meeting held on 22 January 2015
capital market | Mumbai January 23, 2015 09:12 IST
At meeting held on 22 January 2015
India Infoline News Service | Mumbai January 23, 2015 08:29 IST
Biocon Ltd has announced that the Board of Directors of the Company at its meeting held on January 22, 2015, inter alia, has appointed Jeremy Levin and Dr. Vijay Kumar Kuchroo as Additional Independent Directors of the Company.
India Infoline News Service | Mumbai January 23, 2015 08:25 IST
Total Income has increased from Rs. 7195.70 mn for the quarter ended December 31, 2013 to Rs. 7789.90 mn for the quarter ended December 31, 2014.
India Infoline News Service | Mumbai January 22, 2015 08:34 IST
The results which are expected today are Alembic Ltd, Biocon Ltd, Cairn India, Zee Media Corporation, State Bank of Mysore,
Business Wire | January 22, 2015 00:00 IST
Biocon Q3 FY15 Revenues at Rs. 779 Crore, PAT at Rs. 91 Crore
capital market | Mumbai January 13, 2015 11:45 IST
Biocon rose 2.05% to Rs 428.50 at 11:37 IST on BSE after the company concluded sale of 10% stake in its research arm Syngene for Rs 380 crore to IVF Trustee Company.
India Infoline News Service | Mumbai January 13, 2015 11:44 IST
Biocon Research Limited, a wholly owned subsidiary of the Company has concluded such sale to IVF.
capital market | Mumbai January 12, 2015 18:16 IST
Biocon and its subsidiary, Biocon Research jointly hold 85.54% stake in Syngene
capital market | Mumbai January 05, 2015 12:41 IST
On 22 January 2015
India Infoline News Service | Mumbai December 30, 2014 09:53 IST
The stock is now trading at the highest level of the day - with a surge of almost 2 per cent on the BSE.
India Infoline News Service | Mumbai December 29, 2014 09:44 IST
Around 500,000 shares changed hands in a single transaction on the NSE.
India Infoline News Service | Mumbai December 15, 2014 11:19 IST
Report said that Shaw met Andhra Pradesh Chief Minister N. Chandrababu Naidu and informed him of the companys plans to set up a unit in Visakhapatnam.
India Infoline News Service / 09:04, Jan 22, 2015
The outlook is a flat start. The market will look to scale to new peaks though not much effort is needed for the same. HUL saw a rally and short-covering may have pulled it up further. Speculation is on that its parent will raise stake through an open offer. After the cooling in oil prices, Cairn results will be in focus.